Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59


Global, regional, and national causes of child mortality in 2008: a systematic analysis.

Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, Jha P, Campbell H, Walker CF, Cibulskis R, Eisele T, Liu L, Mathers C; Child Health Epidemiology Reference Group of WHO and UNICEF.

Lancet. 2010 Jun 5;375(9730):1969-87. doi: 10.1016/S0140-6736(10)60549-1. Epub 2010 May 11.


Research priorities for health of people with disabilities: an expert opinion exercise.

Tomlinson M, Swartz L, Officer A, Chan KY, Rudan I, Saxena S.

Lancet. 2009 Nov 28;374(9704):1857-62. doi: 10.1016/S0140-6736(09)61910-3.


Setting priorities for global mental health research.

Tomlinson M, Rudan I, Saxena S, Swartz L, Tsai AC, Patel V.

Bull World Health Organ. 2009 Jun;87(6):438-46.


The complex challenge of setting priorities in health research investments.

Rudan I.

Indian J Med Res. 2009 Apr;129(4):351-3. No abstract available.


Phase 1/2 double-blind, placebo-controlled, dose escalation, safety, and pharmacokinetic study of pagibaximab (BSYX-A110), an antistaphylococcal monoclonal antibody for the prevention of staphylococcal bloodstream infections, in very-low-birth-weight neonates.

Weisman LE, Thackray HM, Garcia-Prats JA, Nesin M, Schneider JH, Fretz J, Kokai-Kun JF, Mond JJ, Kramer WG, Fischer GW.

Antimicrob Agents Chemother. 2009 Jul;53(7):2879-86. doi: 10.1128/AAC.01565-08. Epub 2009 Apr 20.


Setting research priorities to reduce global mortality from childhood diarrhoea by 2015.

Fontaine O, Kosek M, Bhatnagar S, Boschi-Pinto C, Chan KY, Duggan C, Martinez H, Ribeiro H, Rollins NC, Salam MA, Santosham M, Snyder JD, Tsai AC, Vargas B, Rudan I.

PLoS Med. 2009 Mar 10;6(3):e41. doi: 10.1371/journal.pmed.1000041. No abstract available.


Staphylococcal vaccines and immunotherapies.

Schaffer AC, Lee JC.

Infect Dis Clin North Am. 2009 Mar;23(1):153-71. doi: 10.1016/j.idc.2008.10.005. Review.


Research priorities to reduce global mortality from newborn infections by 2015.

Bahl R, Martines J, Ali N, Bhan MK, Carlo W, Chan KY, Darmstadt GL, Hamer DH, Lawn JE, McMillan DD, Mohan P, Paul V, Tsai AC, Victora CG, Weber MW, Zaidi AK, Rudan I.

Pediatr Infect Dis J. 2009 Jan;28(1 Suppl):S43-8. doi: 10.1097/INF.0b013e31819588d7.


Setting priorities in global child health research investments: guidelines for implementation of CHNRI method.

Rudan I, Gibson JL, Ameratunga S, El Arifeen S, Bhutta ZA, Black M, Black RE, Brown KH, Campbell H, Carneiro I, Chan KY, Chandramohan D, Chopra M, Cousens S, Darmstadt GL, Meeks Gardner J, Hess SY, Hyder AA, Kapiriri L, Kosek M, Lanata CF, Lansang MA, Lawn J, Tomlinson M, Tsai AC, Webster J; Child Health and Nutrition Research Initiative.

Croat Med J. 2008 Dec;49(6):720-33.


Setting priorities in global child health research investments: universal challenges and conceptual framework.

Rudan I, Chopra M, Kapiriri L, Gibson J, Ann Lansang M, Carneiro I, Ameratunga S, Tsai AC, Chan KY, Tomlinson M, Hess SY, Campbell H, El Arifeen S, Black RE.

Croat Med J. 2008 Jun;49(3):307-17. No abstract available.


Pneumonia caused by methicillin-resistant Staphylococcus aureus.

Rubinstein E, Kollef MH, Nathwani D.

Clin Infect Dis. 2008 Jun 1;46 Suppl 5:S378-85. doi: 10.1086/533594. Review.


Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study).

Asghar R, Banajeh S, Egas J, Hibberd P, Iqbal I, Katep-Bwalya M, Kundi Z, Law P, MacLeod W, Maulen-Radovan I, Mino G, Saha S, Sempertegui F, Simon J, Santosham M, Singhi S, Thea DM, Qazi S; Severe Pneumonia Evaluation Antimicrobial Research Study Group.

BMJ. 2008 Jan 12;336(7635):80-4. doi: 10.1136/bmj.39421.435949.BE. Epub 2008 Jan 8.


Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan.

Zhu W, Clark NC, McDougal LK, Hageman J, McDonald LC, Patel JB.

Antimicrob Agents Chemother. 2008 Feb;52(2):452-7. Epub 2007 Dec 3.


Setting priorities in global child health research investments: addressing values of stakeholders.

Kapiriri L, Tomlinson M, Chopra M, El Arifeen S, Black RE, Rudan I; Child Health and Nutrition Research Initiative (CHNRI).

Croat Med J. 2007 Oct;48(5):618-27. Review.


Setting priorities in global child health research investments: assessment of principles and practice.

Rudan I, Gibson J, Kapiriri L, Lansang MA, Hyder AA, Lawn J, Darmstadt GL, Cousens S, Bhutta ZA, Brown KH, Hess SY, Black M, Gardner JM, Webster J, Carneiro I, Chandramohan D, Kosek M, Lanata CF, Tomlinson M, Chopra M, Ameratunga S, Campbell H, El Arifeen S, Black RE; Child Health and Nutrition Research Initiative (CHNRI).

Croat Med J. 2007 Oct;48(5):595-604.


Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia.

Rupp ME, Holley HP Jr, Lutz J, Dicpinigaitis PV, Woods CW, Levine DP, Veney N, Fowler VG Jr.

Antimicrob Agents Chemother. 2007 Dec;51(12):4249-54. Epub 2007 Sep 24.


Setting priorities in child health research investments for South Africa.

Tomlinson M, Chopra M, Sanders D, Bradshaw D, Hendricks M, Greenfield D, Black RE, El Arifeen S, Rudan I.

PLoS Med. 2007 Aug;4(8):e259. No abstract available.


Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants.

DeJonge M, Burchfield D, Bloom B, Duenas M, Walker W, Polak M, Jung E, Millard D, Schelonka R, Eyal F, Morris A, Kapik B, Roberson D, Kesler K, Patti J, Hetherington S.

J Pediatr. 2007 Sep;151(3):260-5, 265.e1. Epub 2007 Jul 24.


Intermediate vancomycin susceptibility in a community-associated MRSA clone.

Graber CJ, Wong MK, Carleton HA, Perdreau-Remington F, Haller BL, Chambers HF.

Emerg Infect Dis. 2007 Mar;13(3):491-3.

Supplemental Content

Support Center